Shone G R, Richards S H, Hourihan M D, Hall R, Thomas J P, Scanlon M F
Department of Otolaryngology, University Hospital of Wales, Heath Park, Cardiff.
J R Soc Med. 1991 Mar;84(3):140-3. doi: 10.1177/014107689108400308.
A consecutive series of 35 clinically non-secretory pituitary adenomas treated surgically by the transethmodial approach is presented. Mean age at presentation was 60 years, with a male-to-female ratio of 2:1. These tumours present later than hormone secreting tumours: 90% were over 2 cm in diameter at operation. Seventy-one per cent of patients had impaired vision and 89% had hypopituitarism. Surgical treatment relieved or significantly improved visual fields in 79% of patients with impaired vision. Ninety-one per cent required permanent hormone replacement. Mean follow-up was for 4.4 years. Five tumours recurred, causing recurrent visual symptoms. No tumours recurred in those patients treated with postoperative radiotherapy, but follow-up in this group was only for a mean of 2.7 years.
本文报告了连续35例经鼻内镜手术治疗的临床无分泌功能垂体腺瘤。就诊时的平均年龄为60岁,男女比例为2:1。这些肿瘤比分泌激素的肿瘤出现得晚:90%在手术时直径超过2厘米。71%的患者视力受损,89%的患者有垂体功能减退。手术治疗使79%视力受损的患者视野得到缓解或显著改善。91%的患者需要长期激素替代治疗。平均随访4.4年。5例肿瘤复发,导致视觉症状复发。接受术后放疗的患者无肿瘤复发,但该组平均随访仅2.7年。